Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology
by
Carvill, Gemma L.
, Demarest, Scott
, Matheny, Tyler
, Hesselberth, Jay
in
Antisense oligonucleotides
/ Antisense therapy
/ Biomedical and Life Sciences
/ Biomedicine
/ Epilepsy
/ Epilepsy - genetics
/ Epilepsy - therapy
/ Gain of Function Mutation - drug effects
/ Gain of Function Mutation - genetics
/ Gene Editing - methods
/ Gene therapy
/ Genetic Therapy - methods
/ Genetics
/ Genome editing
/ Genomic imprinting
/ Haploinsufficiency
/ Haploinsufficiency - drug effects
/ Haploinsufficiency - genetics
/ Humans
/ Neurobiology
/ Neurology
/ Neurosciences
/ Neurosurgery
/ Oligonucleotides, Antisense - therapeutic use
/ Precision Medicine - methods
/ Precision therapies
/ Review
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology
by
Carvill, Gemma L.
, Demarest, Scott
, Matheny, Tyler
, Hesselberth, Jay
in
Antisense oligonucleotides
/ Antisense therapy
/ Biomedical and Life Sciences
/ Biomedicine
/ Epilepsy
/ Epilepsy - genetics
/ Epilepsy - therapy
/ Gain of Function Mutation - drug effects
/ Gain of Function Mutation - genetics
/ Gene Editing - methods
/ Gene therapy
/ Genetic Therapy - methods
/ Genetics
/ Genome editing
/ Genomic imprinting
/ Haploinsufficiency
/ Haploinsufficiency - drug effects
/ Haploinsufficiency - genetics
/ Humans
/ Neurobiology
/ Neurology
/ Neurosciences
/ Neurosurgery
/ Oligonucleotides, Antisense - therapeutic use
/ Precision Medicine - methods
/ Precision therapies
/ Review
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology
by
Carvill, Gemma L.
, Demarest, Scott
, Matheny, Tyler
, Hesselberth, Jay
in
Antisense oligonucleotides
/ Antisense therapy
/ Biomedical and Life Sciences
/ Biomedicine
/ Epilepsy
/ Epilepsy - genetics
/ Epilepsy - therapy
/ Gain of Function Mutation - drug effects
/ Gain of Function Mutation - genetics
/ Gene Editing - methods
/ Gene therapy
/ Genetic Therapy - methods
/ Genetics
/ Genome editing
/ Genomic imprinting
/ Haploinsufficiency
/ Haploinsufficiency - drug effects
/ Haploinsufficiency - genetics
/ Humans
/ Neurobiology
/ Neurology
/ Neurosciences
/ Neurosurgery
/ Oligonucleotides, Antisense - therapeutic use
/ Precision Medicine - methods
/ Precision therapies
/ Review
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology
Journal Article
Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology
2021
Request Book From Autostore
and Choose the Collection Method
Overview
This review summarizes the pathogenic mechanisms that underpin the monogenic epilepsies and discusses the potential of novel precision therapeutics to treat these disorders. Pathogenic mechanisms of epilepsy include recessive (null alleles), haploinsufficiency, imprinting, gain-of-function, and dominant negative effects. Understanding which pathogenic mechanism(s) that underlie each genetic epilepsy is pivotal to design precision therapies that are most likely to be beneficial for the patient. Novel therapeutics discussed include gene therapy, gene editing, antisense oligonucleotides, and protein replacement. Discussions are illustrated and reinforced with examples from the literature.
Publisher
Elsevier Inc,Springer International Publishing,Springer Nature B.V
Subject
This website uses cookies to ensure you get the best experience on our website.